New Survey from NCCN Finds Cancer Drug Shortage Management Remains a Moving Target, Impacting Clinical Trials

NCCN shares new data on continued high prevalence for cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.

What’s Under the Roof

Stewart Livsie is the UNM Comprehensive Cancer Center’s manager of maintenance and construction and was honored by the IFMA recently. He was instrumental in securing necessary PPE and other supplies to ensure the UNM Cancer Center remains operational during COVID-19 restrictions. He’s also overseen multimillion dollar expansions to the center.